Provided by Tiger Trade Technology Pte. Ltd.

Cytek BioSciences

4.89
+0.06001.24%
Post-market: 4.960.0700+1.43%19:30 EDT
Volume:1.12M
Turnover:5.51M
Market Cap:635.62M
PE:-7.76
High:5.02
Open:4.81
Low:4.80
Close:4.83
52wk High:6.18
52wk Low:3.28
Shares:129.98M
Float Shares:103.00M
Volume Ratio:0.94
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6300
EPS(LYR):-0.5209
ROE:-23.04%
ROA:-6.31%
PB:1.97
PE(LYR):-9.39

Loading ...

Cytek Biosciences, Sysmex Europe Collaborate to Deliver Clinical Flow Cytometry Workflows

MT Newswires Live
·
Sep 09

Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry

THOMSON REUTERS
·
Sep 09

Cytek Biosciences: Sysmex & Cytek to Offer Integrated End-to-End Flow Cytometry Solutions

THOMSON REUTERS
·
Sep 09

Cytek Biosciences to Showcase Spectral Flow Cytometry at ESCCA 2026 Conference

Reuters
·
Sep 04

Cytek Biosciences Shares Drop After Jury Says it Owes $56 Million in Damages

Dow Jones
·
Aug 24

Cytek Owes Beckman Coulter $56 Mln in Cell-Analysis Patent Case, US Jury Says

Reuters
·
Aug 22

Cytek Biosciences: Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; to Challenge Remaining Finding

THOMSON REUTERS
·
Aug 22

Cytek Biosciences: Jury Awarded Past Damages Consisting of $20 Mln in Lost Profits and $36 Mln in Royalties

THOMSON REUTERS
·
Aug 22

Cytek Wins on Most Beckman Patent Claims; Jury Awards $56 Million Damages on Remaining Count

Reuters
·
Aug 22

10x Genomics Q2 Revenue Rises on Atera Demand

Reuters
·
Aug 07

Cytek Biosciences, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Cytek Biosciences Q2 GAAP Net Loss Widens to $12.2 Million; Revenue Rises 6% Year over Year to $48.1 Million

Reuters
·
Aug 06

Cytek Biosciences Q2 EPS $(0.09), Inline, Sales $48.140M Miss $48.610M Estimate

Benzinga Earnings
·
Aug 06

Cytek Biosciences Q2 Revenue USD 48.14 Million

Reuters
·
Aug 06

Cytek Biosciences Q2 Adjusted Ebitda USD -1.541 Million

THOMSON REUTERS
·
Aug 06

Cytek Biosciences Q2 Adjusted Gross Margin 59%

THOMSON REUTERS
·
Aug 06

Cytek Biosciences, Inc. Expected to Post a Loss of 8 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Cytek Biosciences Schedules Second-quarter Results Webcast

Reuters
·
Jul 23

Cytek Biosciences Opens Innovation Center in Washington

MT Newswires Live
·
Jul 16

Cytek Biosciences Chief Legal Officer Valerie Barnett Exits, Takes USD 365,775.12 Severance

Reuters
·
Jul 16